PMC:7443692 / 44453-44713
Annnotations
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T14 | 217-240 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | neutralizing antibodies | http://purl.bioontology.org/ontology/MEDDRA/10058063 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T264 | 0-260 | Sentence | denotes | Finally, it will be important to monitor the slow evolution of the virus to determine if existing sites of glycosylation are lost or new sites emerge with selective pressure that might alter the efficacy of vaccines, neutralizing antibodies, and/or inhibitors. |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T136 | 67-72 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T137 | 98-103 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T138 | 137-142 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T107 | 107-120 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T103 | 107-120 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |